Trials / Recruiting
RecruitingNCT07030010
Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses
Examining the Efficacy of a Commercially Available Multi-ingredient Liquid Tonic Drink on Postprandial Glycemia in Men and Women With Overweight and/or Obesity.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Australian Catholic University · Academic / Other
- Sex
- All
- Age
- 30 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
A randomised, double blinded, placebo-controlled crossover design clinical trial conducted at the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with overweight/ obesity. This study will measure the postprandial glucose and hormone responses to a high-carbohydrate meal with/ without a liquid tonic drink.
Detailed description
Twenty individuals living with overweight/ obesity will be invited to attend the university laboratories on 2 separate occasions to participate in a postprandial (meal) challenge. Participants will consume the same high-carbohydrate meal on each visit, with or without a liquid tonic drink. This will be a cross-over design study, where participants will consume a placebo drink on the alternate visit. Participants will remain in the laboratory for 3-hours following the meal with a venous cannula in place, and have blood samples taken at regular timepoints. Blood samples will be analysed for glucose and appetite hormones. Participants will also wear a continuous glucose monitor throughout the period which encapsulates both study trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Breakfast meal challenge with tonic drink | High-carbohydrate containing breakfast meal with the addition of the tonic drink |
| OTHER | Breakfast meal challenge with placebo drink | High-carbohydrate containing breakfast meal with the addition of the placebo drink |
Timeline
- Start date
- 2025-07-08
- Primary completion
- 2025-12-19
- Completion
- 2025-12-19
- First posted
- 2025-06-19
- Last updated
- 2025-07-23
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07030010. Inclusion in this directory is not an endorsement.